© 2021 Nova Medical US, Inc. Tel: (123) 456 7890
© 2021 Nova Medical US, Inc.. Vestibulum | Sed vulputate
In everything that we do at Nova Medical Laboratories, our primary focus is the patient. Rather than developing “me-too” products, we are tackling serious diseases and disorders to improve or save the lives of patients who are suffering. Our journey is a partnership – a partnership with physicians, regulators, and patients and their families – to develop the most effective and safe therapeutics possible. Targeting important receptors or enzymes never before drugged as well as indications with no approved treatments, we have a track record of succeeding where others have not and remain unrelenting in our efforts to benefit patients everywhere.
Antibody Development
Our proprietary ex vivo platform for the discovery of novel, high-affinity monoclonal antibodies utilizes a chicken B-cell lymphoma cell line. Using our platform and other know-how and techniques, we have generated antibodies against several clinically significant targets, including highly potent antibodies against MASP-2, MASP-3 and MASP-1. We continue to add antibodies to our development pipeline against these and other important targets.
Now more than ever, we are working to ensure that patients have access to and can afford their critical Nova Medical Laboratories medications. In the U.S., Nova Medical Laboratories has implemented changes to its patient assistance programs as part of the company's ongoing commitment to ensuring that patients have access to our products. Nova Medical Laboratories Pharma Support SolutionsSM offers support to patients needing access and reimbursement assistance.
